Cardiovascular mortality is the most common cause of death in end stage renal disease (ESRD) patients. Kidney dysfunction caused cardiovascular changes such as fluid overload, uremic myopathy, secondary hyperparathyroidism, anemia, dyslipidemia, and uremic toxins accumulation like trimethylamine N-oxidase may lead to cardiovascular disease in ESRD patients. Furthermore, myocardial injury and cardiovascular damage may also result in hemodialysis per se. We reviewed the nontraditional risk factors of cardiovascular changes in ESRD, hemodialysis-induced myocardial injury, and possible management strategies.